Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 816  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
ORIGINAL ARTICLE
Year : 2018  |  Volume : 63  |  Issue : 6  |  Page : 479-483

Evaluation of Treponema pallidum hemagglutination assay among varying titers of the venereal disease research laboratory test


Department of Microbiology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India

Correspondence Address:
Dr. Bineeta Kashyap
Flat No. C-402, Vimal CGHS LTD., Plot-3, Sector-12, Dwarka, New Delhi - 110 078
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijd.IJD_595_17

Rights and Permissions

Background and Objective: Syphilis, besides being a significant cause of perinatal morbidity and mortality, is a substantial cause of adult morbidity. A discordant serological result can present a diagnostic challenge; hence, a fundamental knowledge about the diagnostic limitations or interpretation of these assays becomes imperative for the clinicians to avoid management dilemma. The study was proposed to see the usefulness and correlation of Treponema pallidum hemagglutination assay (TPHA) with varying titers of Venereal Disease Research Laboratory (VDRL) test. Materials and Methods: Over a period of 2 years, 22,351 sera were subjected to screening for syphilis by VDRL test. TPHA test was performed for confirmation in 243 of the total sera. Results: VDRL reactivity was seen in 0.77% of the tested sera. TPHA positivity was 58.85% among the sera tested. Calculated sensitivity, specificity, positive predictive value, and negative predictive value of VDRL against TPHA were 87.41%, 52%, 72.25%, and 74.29%, respectively. TPHA positivity was found to be 100% and 55% in VDRL reactive cases with titers ≥32 and <8, respectively. Conclusion: Screening and diagnostic serological tests for syphilis should be reviewed in routine by the treating physician in the light of clinical presentation and the history of infection and treatment.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed170    
    Printed2    
    Emailed0    
    PDF Downloaded25    
    Comments [Add]    

Recommend this journal